Bifogade filer
Carasent group signs contract to supply Medrave M4 to VGR
Kurs
-0,21%
Prenumeration
Kalender
| Tid* | ||
| 2025-02-13 | 07:00 | Bokslutskommuniké 2024 |
| 2024-10-24 | - | Kvartalsrapport 2024-Q3 |
| 2024-10-04 | - | Extra Bolagsstämma 2024 |
| 2024-07-12 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-24 | - | Kvartalsrapport 2024-Q1 |
| 2024-04-18 | - | X-dag ordinarie utdelning CARA 0.00 SEK |
| 2024-04-17 | - | Årsstämma |
| 2024-02-15 | - | Bokslutskommuniké 2023 |
| 2023-11-15 | - | X-dag bonusutdelning CARA 1.84 |
| 2023-11-14 | - | Extra Bolagsstämma 2023 |
| 2023-10-26 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-14 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-04 | - | Kvartalsrapport 2023-Q1 |
| 2023-05-04 | - | X-dag ordinarie utdelning CARA 0.00 SEK |
| 2023-05-03 | - | Årsstämma |
| 2023-02-15 | - | Bokslutskommuniké 2022 |
| 2022-10-26 | - | Kvartalsrapport 2022-Q3 |
| 2022-10-19 | - | Extra Bolagsstämma 2022 |
| 2022-07-15 | - | Kvartalsrapport 2022-Q2 |
| 2022-04-29 | - | X-dag ordinarie utdelning CARA 0.00 SEK |
| 2022-04-28 | - | Årsstämma |
| 2022-04-28 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-10 | - | Bokslutskommuniké 2021 |
| 2021-10-27 | - | Extra Bolagsstämma 2021 |
| 2021-10-27 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-18 | - | Kvartalsrapport 2021-Q2 |
| 2021-06-30 | - | Årsstämma |
| 2021-06-04 | - | X-dag ordinarie utdelning CARA 0.00 SEK |
| 2021-04-28 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-16 | - | Bokslutskommuniké 2020 |
| 2020-10-22 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-13 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-17 | - | Årsstämma |
| 2020-04-29 | - | X-dag ordinarie utdelning CARA 0.00 SEK |
| 2020-04-28 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-12 | - | Bokslutskommuniké 2019 |
| 2019-11-13 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-21 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-23 | - | Split CARA 4:1 |
| 2019-05-16 | - | X-dag ordinarie utdelning CARA 0.00 SEK |
| 2019-05-15 | - | Årsstämma |
| 2019-05-15 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-13 | - | Bokslutskommuniké 2018 |
| 2018-11-14 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-15 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-11 | - | X-dag ordinarie utdelning CARA 0.35 SEK |
| 2018-05-09 | - | Årsstämma |
| 2018-05-09 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-14 | - | Bokslutskommuniké 2017 |
| 2017-11-15 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-16 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-11 | - | X-dag ordinarie utdelning CARA 0.00 SEK |
| 2017-05-10 | - | Årsstämma |
| 2017-05-10 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-28 | - | Bokslutskommuniké 2016 |
| 2016-12-14 | - | X-dag bonusutdelning CARA 1.65 |
| 2016-12-13 | - | Extra Bolagsstämma 2016 |
| 2016-11-16 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-10 | - | Kvartalsrapport 2016-Q2 |
| 2016-06-16 | - | X-dag ordinarie utdelning CARA 0.00 SEK |
| 2016-06-15 | - | Årsstämma |
| 2016-05-04 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-10 | - | Bokslutskommuniké 2015 |
| 2015-11-27 | - | X-dag bonusutdelning CARA 1 |
| 2015-11-26 | - | Extra Bolagsstämma 2015 |
| 2015-10-20 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-12 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-07 | - | X-dag ordinarie utdelning CARA 0.00 SEK |
| 2015-05-06 | - | Årsstämma |
| 2015-05-06 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-11 | - | Bokslutskommuniké 2014 |
| 2014-11-06 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-06 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-07 | - | Årsstämma |
| 2014-05-07 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-12 | - | Bokslutskommuniké 2013 |
| 2013-11-07 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-15 | - | Kvartalsrapport 2013-Q2 |
| 2013-05-08 | - | X-dag ordinarie utdelning |
| 2013-05-07 | - | Årsstämma |
| 2013-05-07 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-13 | - | Bokslutskommuniké 2012 |
| 2012-11-07 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-02 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-09 | - | Årsstämma |
| 2012-05-09 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-15 | - | Bokslutskommuniké 2011 |
| 2011-11-16 | - | Kvartalsrapport 2011-Q3 |
| 2011-05-05 | - | X-dag ordinarie utdelning |
| 2011-05-04 | - | Årsstämma |
| 2011-05-04 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-09 | - | Bokslutskommuniké 2010 |
| 2010-11-03 | - | Kvartalsrapport 2010-Q3 |
| 2010-08-04 | - | Kvartalsrapport 2010-Q2 |
| 2010-05-05 | - | Kvartalsrapport 2010-Q1 |
| 2010-05-05 | - | X-dag ordinarie utdelning CARA 0.00 SEK |
| 2010-02-10 | - | Bokslutskommuniké 2009 |
| 2009-05-07 | - | X-dag ordinarie utdelning CARA 0.00 SEK |
| 2008-06-16 | - | Split CARA 5:1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Small Cap Stockholm |
| Sektor | Informationsteknik |
| Industri | Programvara |
Västra Götalands Regionen and Medrave AB have today entered into an agreement to implement Medrave to the EHR system Millennium. The annual recurring revenue from the contract is NOK 11 million, where NOK 6 million is new revenue.
Västra Götalands Regionen (VGR) is changing EHR system and has in connection with this change held a tender for a system for operational monitoring and automatic reporting to quality registries. Medrave won the tender for a 6 years agreement to provide Medrave M4. This is partly replacing the agreement Medrave has to supply Medrave M4 to the old EHR system.
The yearly value of the contract after the implementation process is NOK 11 million with an addition of NOK 2 million of consultancy revenue the first year. VGR is also buying Medrave for the old EHR system and as long as they continue to do so the NOK 4-5 million VGR is paying for that solution will be subtracted. The new income will start once the implementation is complete which is expected in November 2024.
Carasent CEO Daniel Öhman comments:
- We are very glad that VGR wants to continue and increase the collaboration with Medrave. It is an unrivaled system when it comes to follow-up of primary care quality and automatic reporting to quality registries.
- In a short period of time we have now signed the two largest customer contracts in Carasent’s history. Signed but not implemented ARR is now approximately NOK 14 million (NOK 6 million from the new VGR agreement) up from NOK 2 million Q1 2023. Revenue growth is the key to drive our profit margins given that we aim to keep the cost base flat, and this new ARR will contribute significantly, as our gross margins are over 80%.
About Medrave Software AB
Founded in 1996, Medrave Software AB is a distinguished leader in healthcare business intelligence solutions. Acquired by the Carasent Group in December 2021, Medrave offers an unparalleled BI platform, meticulously designed in close collaboration with medical professionals. As Sweden's premier solution for accessing and visualizing patient record data, Medrave significantly enhances operational workflows and the quality of care. It is currently used by more than 90% of the primary healthcare centres and 1,000 outpatient clinics across Sweden.
For further details please contact:
Daniel Öhman, CEO Tel: +46 70-855 37 07, or
Svein Martin Bjørnstad, CFO Tel: +47 979 69 493